Who
David Hallett
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Recursion Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Feb 2026
- Last trade
- 17 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Aug 2026filed 18 Aug 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $84K26,657 at $3.16 | filing |
| 17 Aug 2026filed 18 Aug 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $84K26,657 at $3.16 | filing |
| 15 May 2026filed 19 May 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $81K26,657 at $3.04 | filing |
| 15 May 2026filed 19 May 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $81K26,657 at $3.04 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $42K11,908 at $3.49 | filing |
| 17 Feb 2026filed 19 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $42K11,908 at $3.49 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —502,064 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —24,254 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $45K11,400 at $3.98 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —502,064 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —24,254 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | RXRX Recursion PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $45K11,400 at $3.98 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.